Media stories about Jaguar Animal Health (NASDAQ:JAGX) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies positive and negative news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Jaguar Animal Health earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned news articles about the biotechnology company an impact score of 45.5526836477532 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
Several analysts recently commented on JAGX shares. Rodman & Renshaw started coverage on shares of Jaguar Animal Health in a research report on Tuesday, July 11th. They set a “buy” rating and a $2.00 price target on the stock. HC Wainwright set a $2.00 price target on shares of Jaguar Animal Health and gave the company a “buy” rating in a research report on Tuesday, July 11th.
Jaguar Animal Health (JAGX) traded down 18.37% during mid-day trading on Friday, reaching $0.40. 431,883 shares of the company traded hands. Jaguar Animal Health has a 52 week low of $0.34 and a 52 week high of $1.84. The firm’s market capitalization is $43.28 million. The stock’s 50 day moving average price is $0.55 and its 200 day moving average price is $0.76.
About Jaguar Animal Health
Jaguar Health, Inc, formerly Jaguar Animal Health, Inc, is a natural-products pharmaceuticals company. The Company is focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals on a global basis. The Company, through its subsidiary Napo Pharmaceuticals, Inc, is focused on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.
Receive News & Ratings for Jaguar Animal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Animal Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
